CT52923 is a selective, orally active antagonist of platelet-derived growth factor receptor (PDGFR), functioning as an ATP-competitive inhibitor. It has versatile applications for researching pathological diseases such as atherosclerosis, glomerulonephritis, liver cirrhosis, pulmonary fibrosis, and cancer.
Molecular Weight:
467.54
Purity:
99.88%
CAS Number:
[205256-55-9]
Formula:
C23H25N5O4S
Target:
PDGFR
T60226
* VAT and and shipping costs not included. Errors and price changes excepted
